EE373 Cost-Effectiveness of Statins, Ezetimibe and PCSK9 Inhibitor for Secondary Prevention of Cardiovascular Disease

Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.621
https://www.valueinhealthjournal.com/article/S1098-3015(22)00822-1/fulltext
Title : EE373 Cost-Effectiveness of Statins, Ezetimibe and PCSK9 Inhibitor for Secondary Prevention of Cardiovascular Disease
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00822-1&doi=10.1016/j.jval.2022.04.621
First page :
Section Title :
Open access? : No
Section Order : 10555
Categories :
Tags :
Regions :
ViH Article Tags :